Skip to content

CMT-07-08: The PROstate Bed Evaluation Study

The Probe Study - The PROstate Bed Evaluation - A Study to Record the Implant Experience, Transponder Stability and Tracking Data of the Calypso 4D Localization Study in the Prostate Bed

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00763152
Enrollment
12
Registered
2008-09-30
Start date
2008-09-30
Completion date
2009-08-31
Last updated
2015-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

prostate, prostate bed, periprostatic

Brief summary

This is an observational study to collect placement and tracking data for patients who have the Calypso transponders implanted into the peri-prostatic tissue.

Detailed description

Use of Real-time tracking using Calypso Electromagnetic Beacons in the prostatic bed of patients receiving radiotherapy following radical prostatectomy.

Interventions

OTHERObservation of transponder stability

Observation of transponder stability and placement in the prostatic bed following radical prostatectomy

Sponsors

Varian, a Siemens Healthineers Company
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients with recurrence of prostate cancer following radical prostatectomy for prostate adenocarcinoma 2. Patients with initially undetectable PSA following prostatectomy for prostate adenocarcinoma with subsequent PSA relapse 3. Patients being planned for radiation therapy 4. Patient is being planned for implant with Calypso Transponders in the prostate bed 5. No evidence of distant metastases 6. Age ≥ 18 years 7. Informed consent

Exclusion criteria

1. The patient has received other investigational therapy in the last 60 days 2. The patient has previously been implanted with permanent beacon transponders 3. The patient has a prosthetic implant in the pelvic region that contain metal or conductive materials 4. The patient has any other medical or other condition that would, in the investigator's opinion, make them a poor candidate for the study

Design outcomes

Primary

MeasureTime frame
To collect data on the process of implanting the Calypso Transponder in the prostate bed following radical prostatectomyImmediate

Secondary

MeasureTime frame
Evaluate the stability of the Calypso transponder in the prostate bed60 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026